The Australian share market is in the red on Friday, with the S&P/ASX 300 Index (ASX: XKO) down 0.51%.
But as always, there are outliers within the pack.
Here are three ASX 300 shares reaching new multi-year highs today.
3 ASX 300 shares hitting new price peaks on Friday
Sigma Healthcare Ltd (ASX: SIG)
The Sigma Healthcare share price lifted to an almost two-decade high of $3.05 on Friday.
Sigma Healthcare owns a network of chemists, including Amcal, Discount Drug Stores, and Guardian Pharmacy. The company has no news for the market today.
However, the ASX 300 healthcare share continues to enjoy upward momentum as investors wait for the finalisation of merger plans with the privately owned Chemist Warehouse pharmaceutical chain.
The Australian Competition & Consumer Commission (ACCC) green-lighted the deal in November.
Sigma Healthcare shares have risen 214% over the past 12 months.
The company was one of 16 ASX shares that doubled in value in 2024.
Sigma was also among the top 5 best-performing healthcare stocks of the year.
Select Harvests Ltd (ASX: SHV)
The Select Harvests share price lifted to a 52-week peak of $4.69 despite no news from the company today.
Select Harvests is one of Australia's largest almond producers.
Last month, broker UBS placed a buy rating on the stock with a 12-month price target of $4.40.
This is largely due to a positive outlook for almond prices.
UBS predicts the almond price will rise to $8.50 per kilo, which is substantially higher than its previous forecasts of $8.10 in FY25 and $8.20 in FY26.
The long-term average price is $8 per kilo.
The ASX 300 consumer staples share has risen 65% over the past 12 months.
Insignia Financial Ltd (ASX: IFL)
The Insignia Financial share price lifted to a three-year high of $4.14 per share on Friday.
Shares in the financial services company have lifted this week after Insignia announced it had received a confidential, non-binding, and indicative proposal from CC Capital Partners.
The offer was $4.30 cash per share, which was a 21.4% share price premium at the time. It was also a 7.5% premium to Bain Capital's offer, which Insignia rejected last month.
The company issued a statement today in response to an article in The Australian newspaper. The article was about speculation that Brookfield was actively considering making a bid for Insignia Financial.
Insignia said it had not received any proposal from Brookfield.
The ASX 300 financial share has risen 66% over the past 12 months.
